Debra Wertz

484 total citations
24 papers, 369 citations indexed

About

Debra Wertz is a scholar working on Economics and Econometrics, Physiology and Surgery. According to data from OpenAlex, Debra Wertz has authored 24 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 6 papers in Physiology and 5 papers in Surgery. Recurrent topics in Debra Wertz's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Asthma and respiratory diseases (5 papers). Debra Wertz is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Asthma and respiratory diseases (5 papers). Debra Wertz collaborates with scholars based in United States, Australia and Switzerland. Debra Wertz's co-authors include Vincent J. Willey, Judith J. Stephenson, Mark J. Cziraky, Michael Pollack, Rhonda L. Bohn, Siddhesh Kamat, Gerald M. Borok, Marcia F.T. Rupnow, Michael Bullano and Sean D. Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and Mayo Clinic Proceedings.

In The Last Decade

Debra Wertz

23 papers receiving 353 citations

Peers

Debra Wertz
Clara Fitzgerald United States
Silvia Calabria Italy
Elizabeth Dee United States
Pranav Gandhi United States
Amie T. Joyce United States
Heike U. Krämer Germany
Namiko A. Goto Netherlands
Moa P. Lee United States
Ritesh Kumar India
Andrew Palsgrove United States
Clara Fitzgerald United States
Debra Wertz
Citations per year, relative to Debra Wertz Debra Wertz (= 1×) peers Clara Fitzgerald

Countries citing papers authored by Debra Wertz

Since Specialization
Citations

This map shows the geographic impact of Debra Wertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Wertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Wertz more than expected).

Fields of papers citing papers by Debra Wertz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Wertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Wertz. The network helps show where Debra Wertz may publish in the future.

Co-authorship network of co-authors of Debra Wertz

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Wertz. A scholar is included among the top collaborators of Debra Wertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Wertz. Debra Wertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Accortt, Neil A., et al.. (2021). Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer. Future Oncology. 17(36). 5119–5127. 10 indexed citations
2.
Accortt, Neil A., et al.. (2021). Demographics and clinical characteristics of metastatic colorectal cancer patients treated with bevacizumab-awwb in real-world oncology clinics.. Journal of Clinical Oncology. 39(3_suppl). 90–90. 1 indexed citations
3.
Ke, Xuehua, Abhishek Kavati, Debra Wertz, et al.. (2018). Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab. Clinical Therapeutics. 40(7). 1140–1158.e4. 10 indexed citations
4.
Ke, Xuehua, Abhishek Kavati, Debra Wertz, et al.. (2018). Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States. Journal of Managed Care & Specialty Pharmacy. 24(7). 598–606. 7 indexed citations
5.
Stephenson, Judith J., Debra Wertz, Tao Gu, Jeetvan Patel, & Anand A. Dalal. (2017). Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting. International Journal of COPD. Volume 12. 1947–1959. 17 indexed citations
6.
Ke, Xuehua, Abhishek Kavati, Debra Wertz, et al.. (2017). Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States. Journal of Managed Care & Specialty Pharmacy. 24(7). 1–11. 5 indexed citations
7.
Wang, Liya, Xuehua Ke, Abhishek Kavati, et al.. (2017). Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria. Current Medical Research and Opinion. 34(1). 35–39. 10 indexed citations
8.
Marvel, Jessica, Xuehua Ke, Tzy‐Chyi Yu, et al.. (2016). Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD. International Journal of COPD. Volume 11. 1689–1703. 21 indexed citations
9.
Jacobson, Terry A., Debra Wertz, Andreas Kuznik, & Mark J. Cziraky. (2013). Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin. Current Medical Research and Opinion. 29(7). 773–781. 2 indexed citations
10.
Simpson, Ross J., Kaan Tunceli, Dena Rosen Ramey, et al.. (2013). Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting. Journal of clinical lipidology. 7(5). 399–407. 24 indexed citations
11.
Wertz, Debra, Chun‐Lan Chang, Judith J. Stephenson, Jie Zhang, & Robert J. Kuhn. (2011). Economic impact of tobramycin in patients with cystic fibrosis in a managed care population. Journal of Medical Economics. 14(6). 759–768. 11 indexed citations
12.
Lafeuille, Marie‐Hélène, Mei Sheng Duh, Jie Zhang, et al.. (2011). Concomitant Asthma Medication Use in Patients Receiving Omalizumab: Results from Three Large Insurance Claims Databases. Journal of Asthma. 48(9). 923–930. 5 indexed citations
13.
Wertz, Debra, Michael Pollack, Keith Rodgers, et al.. (2010). Impact of asthma control on sleep, attendance at work, normal activities, and disease burden. Annals of Allergy Asthma & Immunology. 105(2). 118–123. 41 indexed citations
14.
Wertz, Debra, et al.. (2009). Resource utilization impact of topiramate for migraine prevention in the managed-care setting. Current Medical Research and Opinion. 25(2). 499–503. 7 indexed citations
15.
Sacco, Patricia, Debra Wertz, Michael Pollack, et al.. (2009). Impact of Asthma Control on Quality of Life. Journal of Allergy and Clinical Immunology. 123(2). S115–S115. 1 indexed citations
16.
Wertz, Debra, et al.. (2008). Persistence with Migraine Prophylactic Treatment and Acute Migraine Medication Utilization in the Managed Care Setting. Clinical Therapeutics. 30(12). 2452–2460. 29 indexed citations
17.
Jhaveri, Mehul, Brian Seal, Michael Pollack, & Debra Wertz. (2007). Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Current Medical Research and Opinion. 23(6). 1431–1443. 15 indexed citations
18.
Bullano, Michael, Siddhesh Kamat, Debra Wertz, et al.. (2007). Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting. American Journal of Health-System Pharmacy. 64(3). 276–284. 17 indexed citations
19.
Bullano, Michael, Debra Wertz, Siddhesh Kamat, et al.. (2006). Effect of Rosuvastatin Compared with Other Statins on Lipid Levels and National Cholesterol Education Program Goal Attainment for Low‐Density Lipoprotein Cholesterol in a Usual Care Setting. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(4). 469–478. 51 indexed citations
20.
Hansen, Robert C., H. M. Keener, Edward M. Croom, et al.. (1999). Taxus and taxol: a compilation of research findings. The Knowledge Bank (The Ohio State University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clara Fitzgerald Breakdown of academic impact, for papers by Silvia Calabria Breakdown of academic impact, for papers by Elizabeth Dee Breakdown of academic impact, for papers by Pranav Gandhi Breakdown of academic impact, for papers by Amie T. Joyce Breakdown of academic impact, for papers by Heike U. Krämer Breakdown of academic impact, for papers by Namiko A. Goto Breakdown of academic impact, for papers by Moa P. Lee Breakdown of academic impact, for papers by Ritesh Kumar Breakdown of academic impact, for papers by Andrew Palsgrove
Rankless by CCL
2026